New Early Alzheimer’s Drug Not All It’s Cracked Up To Be
Scientists could barely hold back their excitement following publication of a new clinical drug trial for Alzheimer’s. They described the trial as “a historic moment”, “a new era” and “the beginning of the end”. The results convinced the FDA to grant the drug accelerated approval. However, some experts are saying “not so fast.” That’s because [...]